Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts North American Mining Conferences Presentation September 9, 2025 JLL Signs Non-Binding LOI to List McDermitt on a US Exchange September 9, 2025 Fortune Bay: Maximizing Shareholder Value in Gold and Uranium September 9, 2025